4th Quarter - Report
TAKEDA PHARMACEUTICALS AMERICA, INC. for TAKEDA PHARMACEUTICALS AMERICA INC
Income
—
Expenses
$188,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Tax Reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREW KAPLAN | — |
Health Issues HCR
H.R. 6: 21st Century Cures/Innovation Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREW KAPLAN New | — |
| SHELLEY STEWART | — |
Medicare/Medicaid MMM
Part D Protected classes provision of Affordable Care Act (S648); CMS Part B Demo; Notice of Benefit and Payment Parameters for 2018
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURA ELIZABETH CLINE | — |
| ANDREW KAPLAN | — |
| SHELLEY STEWART | — |
| DEBORAH LYNN WALTER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.